Gregory Schultz, PhD
Dr. Gregory Schultz received a PhD in Biochemistry from Oklahoma State University in 1976 then completed three years of post-doctoral study in Cell Biology at Yale University. He was appointed Assistant Professor of Biochemistry at the University of Louisville, School of Medicine in 1979, and was promoted to Associate Professor of Biochemistry and Ophthalmology in 1985. In 1989, Dr. Schultz was appointed Professor of Ob/Gyn at the University of Florida where he established the Institute for Wound Research to study molecular and cellular regulation of healing. Dr. Schultz’s research focuses on the roles of growth factors, cytokines and proteases in normal and chronic wound healing in skin and eye. He has published more than 250 research papers, chapters and review articles, which have been cited more than 6,500 times, and he has over a dozen patents in the area of wound healing that serve as the intellectual property foundation for two biotech companies he has helped to launch. He is a Principle Investigator or Co-Investigator on research grants totaling over $30 million from the National Institutes of Health and pharmaceutical companies, and he is a consultant for multiple biotechnology companies. He was recognized as an Innovation Leader by TIME magazine in 2006. He is the Chair of the Wound Bed Preparation Advisory Board, a member of the National Pressure Ulcer Advisory Panel, and he served as President of the Wound Healing Society from 1999-2001. He has served as the primary advisor for over 20 PhD or MS graduate students and trained more than 15 post-doctoral associates. He was awarded a Medicinae Doctorem (h.c.) degree from Linkoping University, Sweden in 1996, and he received the Basic Science Research Award from the University of Florida, College of Medicine in 2008. He was recognized as the International Educator of the Year for the College of Medicine in 2008, and he was recognized as an Exemplary Educator in the College of Medicine in 2009.